Hyperlipidemia.
Stewart J, McCallin T, Martinez J, Chacko S, Yusuf S.
Pediatr Rev. 2020 Aug;41(8):393-402. doi: 10.1542/pir.2019-0053.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
The clinical utility of polygenic risk scores for combined hyperlipidemia.
Dron JS.
Curr Opin Lipidol. 2023 Apr 1;34(2):44-51. doi: 10.1097/MOL.0000000000000865. Epub 2022 Dec 27.
Effectiveness and safety of eleven Chinese patent medicines combined with atorvastatin in the treatment of hyperlipidemia: a network meta-analysis of randomized controlled trials.
Shi Z, Zheng W, Bu Z, Zhou X, Wang X, Song Y, Sun J, Liu JP, Liu ZL.
Front Endocrinol (Lausanne). 2025 Mar 24;16:1523553. doi: 10.3389/fendo.2025.1523553. eCollection 2025.
A moderate-fat diet for combined hyperlipidemia and metabolic syndrome.
Knopp RH, Fish B, Dowdy A, Retzlaff B, Walden C, Rusanu I, Paramsothy P.
Curr Atheroscler Rep. 2006 Nov;8(6):492-500. doi: 10.1007/s11883-006-0025-9.
Treatment of hyperlipidemia with combined niacin-statin regimens.
Guyton JR, Capuzzi DM.
Am J Cardiol. 1998 Dec 17;82(12A):82U-84U; discussion 85-86U. doi: 10.1016/s0002-9149(98)00955-2.
Association between exposure to mixture of heavy metals and hyperlipidemia risk among U.S. adults: A cross-sectional study.
Wang G, Fang L, Chen Y, Ma Y, Zhao H, Wu Y, Xu S, Cai G, Pan F.
Chemosphere. 2023 Dec;344:140334. doi: 10.1016/j.chemosphere.2023.140334. Epub 2023 Oct 1.
Calculating LDL cholesterol in familial combined hyperlipidemia: Out with the old, in with the new?
Martin SS.
Atherosclerosis. 2018 Oct;277:172-174. doi: 10.1016/j.atherosclerosis.2018.07.034. Epub 2018 Jul 27.
Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Zhang LS, Zhang JH, Feng R, Jin XY, Yang FW, Ji ZC, Zhao MY, Zhang MY, Zhang BL, Li XM.
Am J Chin Med. 2019;47(4):751-767. doi: 10.1142/S0192415X19500393. Epub 2019 May 16.
Biomimetic MicroRNAs-Selenium-Nanocomposites for Targeted and Combined Hyperlipidemia Therapy.
Li T, Liu L, Zhu K, Luo Y, Huang X, Dong Y, Huang J.
Adv Healthc Mater. 2024 Jun;13(16):e2400064. doi: 10.1002/adhm.202400064. Epub 2024 Mar 15.
